Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Krakchemia's EBIT per Share for the
three
months ended in Mar. 2026 was zł-0.16.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was zł-0.74.
During the past 3 years, the average EBIT per Share Growth Rate was -21.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Krakchemia's EBIT per Share or its related term are showing as below:
WAR:KCH'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -132.4 Med: 2.3 Max: 50.2
Current: -21.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Krakchemia was 50.20% per year. The lowest was -132.40% per year. And the median was 2.30% per year.
WAR:KCH's 3-Year EBIT Growth Rate is ranked worse than 76.76% of 1338
companies
in the Chemicals industry
Industry Median: -1.15
vs WAR:KCH: -21.10
Krakchemia's EBIT for the
three
months ended in Mar. 2026 was zł-1.42 Mil.
Krakchemia (WAR:KCH) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Krakchemia EBIT per Share Related Terms
Krakchemia EBIT per Share Historical Data
* Premium members only.
The historical data trend for Krakchemia's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.74
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krakchemia (WAR:KCH) has a EBIT per Share of zł-0.74 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Krakchemia and its competitors. According to the industry distribution chart, Krakchemia ranks #1027 out of 1338 companies in the Chemicals industry, placing it in the top 76.8%.
Is Krakchemia's EBIT per Share too high?
Krakchemia's current EBIT per Share is zł-0.74. Based on the distribution chart, Krakchemia ranks #1027 out of 1338 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Krakchemia has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krakchemia's EBIT per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, Krakchemia ranks #1027 out of 1338 companies for EBIT per Share. This places Krakchemia in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Krakchemia and its competitors. Krakchemia's current EBIT per Share is zł-0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krakchemia stock overvalued right now?
Based on GuruFocus' analysis, Krakchemia (WAR:KCH) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.31, compared to a current price of zł0.48 — trading 55.8% above its estimated fair value. The current EBIT per Share is zł-0.74. Krakchemia's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Krakchemia (WAR:KCH), the current EBIT per Share is zł-0.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krakchemia (WAR:KCH) Overvalued in 2026?
Based on GuruFocus' analysis, Krakchemia stock appears to be overvalued.
The current stock price of zł0.48 is trading 55.8% above its estimated GF Value™ of zł0.31.
GuruFocus considers Krakchemia to be Significantly Overvalued.
Key valuation signals for WAR:KCH:
EBIT per Share: zł-0.74
GF Value™: zł0.31 vs. price of zł0.48 (55.8% above fair value)
No single metric tells the full story. See the WAR:KCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krakchemia SA specializes in the wholesale of plastic granulates, laboratory chemicals, and chemical raw materials. The company's main activity is wholesale trade in chemical products, mainly plastic granulates, packaging foils, plastics, reagents, and chemical raw materials. It sells commercial goods on the domestic market and in small quantities abroad, with operations covering Poland, Slovakia, the Czech Republic, Germany, and other foreign markets.
35GF Score
Get the complete analysis for WAR:KCH
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:KCH has been successfully added to your 
